Five Reasons Why mHealth is the Holy Grail of Participatory Medicine


Mobile health or mHealth is a term used for the practice of medicine and public health, supported by mobile devices. The term is most commonly used in reference to using mobile communication devices, such as mobile phones and PDAs, for health services and information. MHealth has been utilized in underdeveloped countries for many years due to inaccessibility to scarce health care resources as well as the widespread use of cell phones. Developments in health care in the Western world have very recently spurned interest in mHealth in developed countries.

  1. A present and worsening shortage of both primary care physicians, and an even greater shortage of specialists, coupled with health care reform which is aimed at increasing access of health care will make face to face care more difficult. This, in some areas, has spurned the telehealth industry, whereby a physician will literally see you over the Internet. Physician shortages and the cost of this technology (most services charge as an office visit and require insurance) limit the widespread potential success of such endeavors. MHealth initiatives will actually increase contact of the provider and patient via text messaging, email, and communication of sensor-derived physiologic data (see below).
  2. Obesity is now the biggest threat to the health of Western countries. It is responsible for the skyrocketing rise of high blood pressure, diabetes, coronary artery disease and even stroke in young people. Most chronic diseases like these are preventable with simple lifestyle changes. MHealth can effect these changes with educational messages, lifestyle reminders, and the transmission of physiologic sensing data (blood pressure, heart rate, blood oxygen levels, EKG tracing, and others).
  3. The cost of health care is now literally prohibitive as a percentage of our total national budget. Technological and pharmaceutical development costs due to research, development and regulatory requirements are also at unsustainable levels. Therefore, both the public and private sectors are embracing mHealth as a solution. The government is making significant funding available for mHealth development. Large medical device companies are looking to smaller mHealth companies as a vital future of their business plans.
  4. The shift of hospital and provider reimbursement from diagnosis-related fee for service management of diseases to to one of outcomes measured goals necessitates better patient participation. MHealth is a tool that can facilitate better patient care coordination once a patient leaves the hospital. It will hopefully prevent many office clinic visits and hospitalizations as well. Outcomes based care will necessitate close provider-patient contact upon hospital discharge. It may decrease the need for home visits by nurses and others due to transmission of information, both clinical and descriptive by the patient.
  5. The advent of more widespread use Meaningful Use of electronic health records (EHRs) is ripe for mHealth. Information from mHealth-derived technologies can deliver clinical information directly into EHRs or even cell phones or PDAs to the patient’s provider. Increasing interoperability of EHRs will lend itself to receiving information from MHealth programs. Educational materials in the patient’s EHR can be transmitted to mHealth applications as well. MHealth programs like medication-adherence, lifestyle changing reminders, and programs related to education of medical procedures (improving informed consent) have been developed. These all interact with EHRs. All viable mHealth technologies will be expected to feed into EHRs. This will maximize transparency, increase access, and result in better care coordination.

In summary, mHealth, is pivotal in participatory medicine’s goal of having the patient be the center of healthcare coordination, ultimately preventing and best treating chronic diseases, which utilize the vast majority of health care resources.

About davidleescher

David Lee Scher, MD is Founder and Director at DLS HEALTHCARE CONSULTING, LLC, which specializes in advising digital health technology companies, their partners, investors, and clients. As a cardiac electrophysiologist and pioneer adopter of remote patient monitoring, he understood early on the challenges that the culture and landscape of healthcare present to the development and adoption of digital technologies. He is a well-respected thought leader in mobile and other digital health technologies. Scher lectures worldwide on relevant industry topics including the role of tech in Pharma, patient advocacy, standards for development and adoption, and impact on patients and healthcare systems from clinical, risk management, operational and marketing standpoints. He is a Clinical Associate Professor of Medicine at Penn State College of Medicine.
This entry was posted in mHealth and tagged , , , , , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s